https://www.selleckchem.com/pr....oducts/ertugliflozin
001; hepatitis C 8% and 38%, respectively, differences P less then .001). Reductions in mean incident cases per state-year mirrored these findings. HIV infection among injection drug users yielded inconsistent results. CONCLUSIONS Hepatitis B and hepatitis C transmission were reduced at the population level in states with SEP laws in a pattern reflecting the degree of legal intervention. HIV infection, based upon a smaller data set, showed a mixed impact. POLICY IMPLICATIONS The results show promise that SEPs have population-level